Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022

SELL
$12.38 - $19.1 $1,386 - $2,139
-112 Closed
0 $0
Q4 2021

Feb 02, 2022

SELL
$16.55 - $27.63 $4,650 - $7,764
-281 Reduced 71.5%
112 $2,000
Q3 2021

Oct 19, 2021

BUY
$20.35 - $26.63 $6,389 - $8,361
314 Added 397.47%
393 $10,000
Q2 2021

Jul 28, 2021

SELL
$16.33 - $33.07 $195 - $396
-12 Reduced 13.19%
79 $2,000
Q1 2021

Apr 28, 2021

BUY
$28.67 - $52.59 $2,608 - $4,785
91 New
91 $3,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.16B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Janiczek Wealth Management, LLC Portfolio

Follow Janiczek Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janiczek Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janiczek Wealth Management, LLC with notifications on news.